FZD7 has a critical role in cell proliferation in triple negative breast cancer
- PMID: 21532620
- DOI: 10.1038/onc.2011.145
FZD7 has a critical role in cell proliferation in triple negative breast cancer
Abstract
Breast cancer is genetically and clinically heterogeneous. Triple negative breast cancer (TNBC) is a subtype of breast cancer that is usually associated with poor outcome and lack of benefit from targeted therapy. We used microarray analysis to perform a pathway analysis of TNBC compared with non-triple negative breast cancer (non-TNBC). Overexpression of several Wnt pathway genes, such as frizzled homolog 7 (FZD7), low density lipoprotein receptor-related protein 6 and transcription factor 7 (TCF7) was observed in TNBC, and we directed our focus to the Wnt pathway receptor, FZD7. To validate the function of FZD7, FZD7shRNA was used to knock down FZD7 expression. Notably, reduced cell proliferation and suppressed invasiveness and colony formation were observed in TNBC MDA-MB-231 and BT-20 cells. Study of the possible mechanism indicated that these effects occurred through silencing of the canonical Wnt signaling pathway, as evidenced by loss of nuclear accumulation of β-catenin and decreased transcriptional activity of TCF7. In vivo studies revealed that FZD7shRNA significantly suppressed tumor formation, through reduced cell proliferation, in mice bearing xenografts without FZD7 expression. Our findings suggest that FZD7-involved canonical Wnt signaling pathway is essential for tumorigenesis of TNBC, and thus, FZD7 shows promise as a biomarker and a potential therapeutic target for TNBC.
Similar articles
-
A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.Int J Biochem Cell Biol. 2018 Oct;103:45-55. doi: 10.1016/j.biocel.2018.08.004. Epub 2018 Aug 7. Int J Biochem Cell Biol. 2018. PMID: 30096373
-
Redundant expression of canonical Wnt ligands in human breast cancer cell lines.Oncol Rep. 2006 Mar;15(3):701-7. Oncol Rep. 2006. PMID: 16465433
-
A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway.J Exp Clin Cancer Res. 2021 Jan 12;40(1):30. doi: 10.1186/s13046-020-01800-x. J Exp Clin Cancer Res. 2021. PMID: 33436039 Free PMC article.
-
The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.J Cell Biochem. 2012 Jan;113(1):13-8. doi: 10.1002/jcb.23350. J Cell Biochem. 2012. PMID: 21898546 Free PMC article. Review.
-
Frizzled7 as an emerging target for cancer therapy.Cell Signal. 2012 Apr;24(4):846-51. doi: 10.1016/j.cellsig.2011.12.009. Epub 2011 Dec 13. Cell Signal. 2012. PMID: 22182510 Free PMC article. Review.
Cited by
-
The expression and function of Frizzled-7 in human renal cell carcinoma.Clin Transl Oncol. 2016 Mar;18(3):269-76. doi: 10.1007/s12094-015-1362-3. Epub 2015 Aug 5. Clin Transl Oncol. 2016. PMID: 26243397
-
Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.Cell Signal. 2012 Dec;24(12):2291-6. doi: 10.1016/j.cellsig.2012.07.009. Epub 2012 Jul 20. Cell Signal. 2012. PMID: 22820499 Free PMC article.
-
Mammary Development and Breast Cancer: A Wnt Perspective.Cancers (Basel). 2016 Jul 13;8(7):65. doi: 10.3390/cancers8070065. Cancers (Basel). 2016. PMID: 27420097 Free PMC article. Review.
-
Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer.Cancer Lett. 2018 Dec 1;438:165-173. doi: 10.1016/j.canlet.2018.09.022. Epub 2018 Sep 15. Cancer Lett. 2018. PMID: 30227220 Free PMC article.
-
Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence.Front Cell Dev Biol. 2020 Jan 31;8:25. doi: 10.3389/fcell.2020.00025. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32083079 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous